AAAAAA
Results: 426-450/1162
Authors:
Lee, BR
Roberts, WW
Smith, DG
Ko, HW
Epstein, JI
Lecksell, K
Partin, AW
Citation: Br. Lee et al., Bioimpedance: Novel use of a minimally invasive technique for cancer localization in the intact prostate, PROSTATE, 39(3), 1999, pp. 213-218
Authors:
Sattler, HP
Rohde, V
Bonkhoff, H
Zwergel, T
Wullich, B
Citation: Hp. Sattler et al., Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer, PROSTATE, 39(2), 1999, pp. 79-86
Authors:
Sintich, SM
Steinberg, J
Kozlowski, JM
Lee, C
Pruden, S
Sayeed, S
Sensibar, JA
Citation: Sm. Sintich et al., Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin), PROSTATE, 39(2), 1999, pp. 87-93
Authors:
Yokomizo, A
Mai, M
Bostwick, DG
Tindall, DJ
Qian, JQ
Cheng, L
Jenkins, RB
Smith, DI
Liu, WG
Citation: A. Yokomizo et al., Mutation and expression analysis of the p73 gene in prostate cancer, PROSTATE, 39(2), 1999, pp. 94-100
Authors:
Tieva, A
Wikstrom, P
Olofsson, JI
Bergh, A
Damber, JE
Citation: A. Tieva et al., Expression of gonadotropin-releasing hormone receptor mRNA in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration, PROSTATE, 39(2), 1999, pp. 101-107
Authors:
Romanov, VI
Goligorsky, MS
Citation: Vi. Romanov et Ms. Goligorsky, RGD-recognizing integrins mediate interactions of human prostate carcinomacells with endothelial cells in vitro, PROSTATE, 39(2), 1999, pp. 108-118
Authors:
Caballes, RL
Caballes, RA
Citation: Rl. Caballes et Ra. Caballes, Primary cryptococcal prostatitis in an apparently uncompromised host, PROSTATE, 39(2), 1999, pp. 119-122
Authors:
Miyake, H
Hara, I
Yamanaka, K
Gohji, K
Arakawa, S
Kamidono, S
Citation: H. Miyake et al., Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer, PROSTATE, 39(2), 1999, pp. 123-129
Authors:
Giovannucci, E
Stampfer, MJ
Chan, A
Krithivas, K
Gann, PH
Hennekens, CH
Kantoff, PW
Citation: E. Giovannucci et al., CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in US physicians, PROSTATE, 39(2), 1999, pp. 130-134
Authors:
Abrahamsson, PA
Citation: Pa. Abrahamsson, Neuroendocrine differentiation in prostatic carcinoma, PROSTATE, 39(2), 1999, pp. 135-148
Authors:
Koga, H
Naito, S
Koto, S
Sakamoto, N
Nakashima, M
Yamasaki, T
Noma, H
Kumazawa, J
Citation: H. Koga et al., Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer, PROSTATE, 39(1), 1999, pp. 1-7
Authors:
Aaltomaa, S
Lipponen, P
Eskelinen, M
Ala-Opas, M
Kosma, VM
Citation: S. Aaltomaa et al., Prognostic value and expression of p21(wafl/cip1) protein in prostate cancer, PROSTATE, 39(1), 1999, pp. 8-15
Authors:
Granfors, T
Bergh, A
Lofroth, PO
Widmark, A
Citation: T. Granfors et al., Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals, PROSTATE, 39(1), 1999, pp. 16-22
Authors:
Tovar-Guzman, V
Hernandez-Giron, C
Lopez-Rios, O
Lazcano-Ponce, EC
Citation: V. Tovar-guzman et al., Prostate cancer mortality trends in Mexico, 1980-1995, PROSTATE, 39(1), 1999, pp. 23-27
Authors:
Tiffany, CW
Lapidus, RG
Merion, A
Calvin, DC
Slusher, BS
Citation: Cw. Tiffany et al., Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase, PROSTATE, 39(1), 1999, pp. 28-35
Authors:
Nilsson, BO
Egevad, L
Jin, MS
Ronquist, G
Busch, C
Citation: Bo. Nilsson et al., Distribution of prostasomes in neoplastic epithelial prostate cells, PROSTATE, 39(1), 1999, pp. 36-40
Authors:
Beerlage, HP
van Leenders, GJLH
Oosterhof, GON
Witjes, JA
Ruijter, ET
van de Kaa, CA
Debruyne, FMJ
de la Rosette, JJMCH
Citation: Hp. Beerlage et al., High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: Results of a prospective study, PROSTATE, 39(1), 1999, pp. 41-46
Authors:
Kolvenbag, GJCM
Nash, A
Citation: Gjcm. Kolvenbag et A. Nash, Bicalutamide dosages used in the treatment of prostate cancer, PROSTATE, 39(1), 1999, pp. 47-53
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment, PROSTATE, 39(1), 1999, pp. 54-59
Authors:
Tefilli, MV
Gheiler, EL
Tiguert, R
Banerjee, M
Sakr, W
Grignon, D
Wood, DP
Pontes, JE
Citation: Mv. Tefilli et al., Role of radical prostatectomy in patients with prostate cancer of high Gleason score, PROSTATE, 39(1), 1999, pp. 60-66
Authors:
Gao, J
Tombal, B
Isaacs, JT
Citation: J. Gao et al., Rapid in situ hybridization technique for detecting malignant mouse cell contamination in human xenograft tissue from nude mice and in vitro culturesfrom such xenografts, PROSTATE, 39(1), 1999, pp. 67-70
Authors:
Guillonneau, B
Vallancien, G
Citation: B. Guillonneau et G. Vallancien, Laparoscopic radical prostatectomy: Initial experience and preliminary assessment after 65 operations, PROSTATE, 39(1), 1999, pp. 71-75
Authors:
Aumuller, G
Renneberg, H
Leonhardt, M
Lilja, H
Abrahamsson, PA
Citation: G. Aumuller et al., Localization of protein gene product 9.5 immunoreactivity in derivatives of the human Wolffian duct and in prostate cancer, PROSTATE, 38(4), 1999, pp. 261-267
Authors:
Wikstrom, P
Westin, P
Stattin, P
Damber, JE
Bergh, A
Citation: P. Wikstrom et al., Early castration-induced upregulation of transforming growth factor beta 1and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients, PROSTATE, 38(4), 1999, pp. 268-277
Authors:
Sakai, H
Tsurusaki, T
Kanda, S
Koji, T
Xuan, JW
Saito, Y
Citation: H. Sakai et al., Prognostic significance of beta-microseminoprotein mRNA expression in prostate cancer, PROSTATE, 38(4), 1999, pp. 278-284